Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Enlighten Study: The EV-ICD Post Approval Registry

NCT06048731 is registered in ClinicalTrials.gov with Medtronic as lead sponsor.

NCT NCT06048731
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06048731 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Enlighten Study: The EV-ICD Post Approval Registry
Lead sponsor
Medtronic
Phase
Observational
Overall status
Active, not recruiting
Start date
September 1, 2023
Completion date
October 31, 2037
Enrollment
1,000 (estimated)
Sites
130

Conditions

As the registry lists them; a condition with its own page is linked.

tachycardia, ventricular arrhythmia